{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:10:33Z","timestamp":1790511033843,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bbmt.2019.09.028","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T17:28:21Z","timestamp":1569518901000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of Cytomegalovirus Reactivation and Natural Killer Reconstitution on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Analysis"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2127-0873","authenticated-orcid":false,"given":"Taiki","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-4459","authenticated-orcid":false,"given":"Takayoshi","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiwa","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.09.028_bib0001","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0002","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","article-title":"Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update","volume":"115","author":"Seggewiss","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fimmu.2018.00389","article-title":"Potential beneficial effects of cytomegalovirus infection after transplantation","volume":"9","author":"Litjens","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0005","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0006","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbmt.2012.10.010","article-title":"Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children","volume":"19","author":"Bartelink","year":"2013","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0007","article-title":"Rapid recovery of CD3+CD8+ T cells on day 90 predicts superior survival after unmanipulated haploidentical blood and marrow transplantation","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0008","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V98.2.489","article-title":"Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation","volume":"98","author":"Storek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0009","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early natural killer cell reconstitution predicts overall survival in T cell replete allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0010","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0011","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0012","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0013","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"Am Stat Assoc J"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0016","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely-available easy-to-use software \u201cEZR\u201d (Easy R) for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0017","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0018","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3324\/haematol.2014.108407","article-title":"Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"99","author":"Kheav","year":"2014","journal-title":"Haemtologica"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0019","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbmt.2018.03.028","article-title":"Control of cytomegalovirus viremia after allogeneic stem cell transplantation: a review on CMV-specific T cell reconstitution","volume":"24","author":"van der Heiden","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/21505594.2016.1221022","article-title":"CMV-specific immune reconstitution following allogeneic stem cell transplantation","volume":"7","author":"Blyth","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0021","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/bloodadvances.2018016493","article-title":"Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation","volume":"2","author":"Chen","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0022","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0023","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0024","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/bmt.2016.89","article-title":"Impact of early CMV reactivation in cord blood stem cell recipients in the current era","volume":"51","author":"Ramanathan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0025","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients","volume":"10","author":"Stern","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0026","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2015.260","article-title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0027","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1086\/522433","article-title":"Cytomegalovirus reactivation in \"immunocompetent\" patients: a call for scientific prophylaxis","volume":"196","author":"Cook","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0028","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/bmt.2013.49","article-title":"CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML","volume":"48","author":"Ito","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0029","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.3390\/ijms20020271","article-title":"CMV-specific immune response-new patients, new insight: central role of specific igg during infancy and long-lasting immune deficiency after allogenic stem cell transplantation","volume":"20","author":"Zdziarski","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0030","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1182\/bloodadvances.2018025908","article-title":"The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia","volume":"3","author":"Keating","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0031","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.leukres.2011.11.009","article-title":"The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation","volume":"36","author":"Tanaka","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2019.09.028_bib0032","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/bloodadvances.2017008631","article-title":"The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT","volume":"1","author":"Maggs","year":"2017","journal-title":"Blood Adv"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119306391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119306391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:09:51Z","timestamp":1761059391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119306391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1083879119306391"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.09.028","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Cytomegalovirus Reactivation and Natural Killer Reconstitution on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Analysis","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}